Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 4
1997 2
2000 3
2002 3
2003 1
2004 1
2005 3
2006 2
2007 3
2008 6
2009 7
2010 7
2011 5
2012 7
2013 6
2014 11
2015 10
2016 18
2017 22
2018 17
2019 9
2020 17
2021 17
2022 12
2023 16
2024 15
2025 18
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM. Tektonidou MG, et al. Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15. Ann Rheum Dis. 2019. PMID: 31092409 Free PMC article.
High-risk antiphospholipid antibody (aPL) profile is associated with greater risk for thrombotic and obstetric APS. ...In patients with APS with first arterial thrombosis, treatment with VKA with INR 2-3 or INR 3-4 is recommended, considering the individual's bleedi …
High-risk antiphospholipid antibody (aPL) profile is associated with greater risk for thrombotic and obstetric APS. ...In patients wi …
Antiphospholipid syndrome.
Petri M. Petri M. Transl Res. 2020 Nov;225:70-81. doi: 10.1016/j.trsl.2020.04.006. Epub 2020 May 12. Transl Res. 2020. PMID: 32413497 Free PMC article. Review.
Classification criteria include 3 different antiphospholipid antibodies: lupus anticoagulant, anticardiolipin, and anti-beta 2 glycoprotein I. Management includes both preventive strategies (low-dose aspirin, hydroxychloroquine) and long-term anticoagulation after …
Classification criteria include 3 different antiphospholipid antibodies: lupus anticoagulant, anticardiolipin, and anti-beta 2 glycop …
Antiphospholipid syndrome.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Ruiz-Irastorza G, et al. Lancet. 2010 Oct 30;376(9751):1498-509. doi: 10.1016/S0140-6736(10)60709-X. Epub 2010 Sep 6. Lancet. 2010. PMID: 20822807 Review.
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency. ...Hydroxychloroquine is a potential additional treatment for this synd …
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for p …
Antiphospholipid syndrome.
Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, Salmon JE, Shoenfeld Y, Shovman O, Hunt BJ. Schreiber K, et al. Nat Rev Dis Primers. 2018 Jan 11;4:17103. doi: 10.1038/nrdp.2017.103. Nat Rev Dis Primers. 2018. PMID: 29321641 Review.
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and anti-beta2-glycoprotein 1 antibodies. APS can present with a variety of clinical phenot
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies, such as
Antiphospholipid syndrome in pregnancy: a comprehensive literature review.
Murvai VR, Galiș R, Panaitescu A, Radu CM, Ghitea TC, Trif P, Onița-Avram M, Vesa AA, Huniadi A. Murvai VR, et al. BMC Pregnancy Childbirth. 2025 Mar 24;25(1):337. doi: 10.1186/s12884-025-07471-w. BMC Pregnancy Childbirth. 2025. PMID: 40128683 Free PMC article.
BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombotic events and adverse obstetric outcomes, particularly in its obstetric form (OAPS). ...RESULTS: The review confirmed that APS current accepted pathogenesis is governed by a "two- …
BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombotic events and adverse obstetric outcome …
Thrombotic antiphospholipid syndrome: From guidelines to clinical management.
Paredes-Ruiz D, Martin-Iglesias D, Ruiz-Irastorza G. Paredes-Ruiz D, et al. Med Clin (Barc). 2024 Aug;163 Suppl 1:S22-S30. doi: 10.1016/j.medcli.2024.02.010. Med Clin (Barc). 2024. PMID: 39174150 Review. English, Spanish.
Thrombotic manifestations, mainly venous thromboembolism (VTE) and stroke, are the most common and potentially life-threatening presentations of antiphospholipid syndrome (APS). The management of APS requires the assessment of the antiphospholipid antibodies (aPL) p …
Thrombotic manifestations, mainly venous thromboembolism (VTE) and stroke, are the most common and potentially life-threatening presentation …
Antiphospholipid Syndrome: State of the Art of Clinical Management.
Depietri L, Veropalumbo MR, Leone MC, Ghirarduzzi A. Depietri L, et al. Cardiovasc Drugs Ther. 2025 Apr;39(2):385-404. doi: 10.1007/s10557-023-07496-3. Epub 2023 Aug 12. Cardiovasc Drugs Ther. 2025. PMID: 37572208 Review.
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically characterized by recurrent arterial and venous thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies. ...Treatment options for the prevention of pregna
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically characterized by recurrent arterial and venous thromb
Systemic Lupus Erythematosus Management in Pregnancy.
Dao KH, Bermas BL. Dao KH, et al. Int J Womens Health. 2022 Feb 15;14:199-211. doi: 10.2147/IJWH.S282604. eCollection 2022. Int J Womens Health. 2022. PMID: 35210867 Free PMC article. Review.
These flares can lead to increased adverse pregnancy outcomes including fetal loss, pre-eclampsia, preterm birth and small for gestational aged infants. In addition, women with antiphospholipid antibodies can have thrombosis during pregnancy or higher rates of fetal …
These flares can lead to increased adverse pregnancy outcomes including fetal loss, pre-eclampsia, preterm birth and small for gestational a …
Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review.
Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A, Marques-Soares J, Pardos-Gea J, Miró-Mur F. Alijotas-Reig J, et al. J Clin Med. 2022 Jan 28;11(3):675. doi: 10.3390/jcm11030675. J Clin Med. 2022. PMID: 35160128 Free PMC article. Review.
Antiphospholipid syndrome is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody positivity. Cases fulfilling the Sydney criteria for obstetric morbidity with no previous
Antiphospholipid syndrome is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity associated
Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.
Petri M. Petri M. Curr Rheumatol Rep. 2011 Feb;13(1):77-80. doi: 10.1007/s11926-010-0141-y. Curr Rheumatol Rep. 2011. PMID: 20978875 Review.
Hydroxychloroquine also has known benefits in reducing some traditional cardiovascular risk factors, such as hyperlipidemia and diabetes mellitus. This article reviews its possible role as an antithrombotic drug in the general population, in systemic lupus erythematosus, a
Hydroxychloroquine also has known benefits in reducing some traditional cardiovascular risk factors, such as hyperlipidemia and diabe
220 results